🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study are to determine 1) Whether Ly333531 can reduce u...
Status
Completed
Location
Multiple Locations
Start Date
2002-07-16
Trial ID
NCT00044148
Treatments Being Tested
Ruboxistaurin is being tested to see if it is effective in treating certain...
Status
Completed
Location
Multiple Locations
Start Date
1999-05
Trial ID
NCT00761852
Treatments Being Tested
This is a randomized, observer-blinded, vehicle-controlled multi-dose trial...
Status
Completed
Location
Zepeda Dermatologia
Start Date
2022-08-18
Trial ID
NCT05511948
Treatments Being Tested
This study evaluates the effect of ruboxistaurin for its safety, tolerabili...
Status
Withdrawn
Location
The Lindner Center for Research and Education at The Christ Hospital
Start Date
2017-06-28
Trial ID
NCT02769611
Treatments Being Tested
The purpose of this protocol is to determine if an investigational drug kno...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2002-07
Trial ID
NCT00044408
Treatments Being Tested
To provide ruboxistaurin treatment to patients who completed the B7A-MC-MBC...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Start Date
2006-01
Trial ID
NCT00266695
Treatments Being Tested
The purpose of this study is to determine whether ruboxistaurin can reduce ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 am to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2002-09
Trial ID
NCT00552227
Treatments Being Tested
This study is to test whether or not 32 milligrams (mg) of ruboxistaurin a ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT -5 hours, EST) or speak with your personal physician.
Start Date
2001-03
Trial ID
NCT00604383
Treatments Being Tested
The purpose of this protocol is to determine if an investigational drug is ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2002-07
Trial ID
NCT00044421
Treatments Being Tested
To determine if protein kinase C beta plays a significant role in vascular ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2003-12
Trial ID
NCT00482976
Treatments Being Tested